0001921963-26-000015
SEC filingAtmus Filtration Technologies Inc. (ATMU) reported strong financial performance for FY 2025 ending December 31, 2025. Net sales reached $1.76B, with gross margin of $498.3M reflecting robust profitability. Operating income stood at $299.0M after selling, general and administrative expenses of $184.3M, research and development of $40.7M, and equity income from investees of $33.8M. Net income was $207.4M, or $3 basic EPS and $2 diluted EPS, on weighted-average shares of 82.2M basic and 82.8M diluted. Balance sheet shows total assets of $1.35B, including $236.4M cash, $892.4M current assets, and $378.5M total equity. Total liabilities were $972.2M, with $570.0M debt. Operating cash flow generated $202.7M, supporting $53.9M capex, $60.7M stock repurchases, $17.3M dividends, and $22.5M debt payments, resulting in $52.1M cash increase. Impairment charges of $8.4M noted. Strong cash generation and profitability position ATMU for sustained filtration technology leadership.
Atmus Filtration Technologies Inc. delivered solid FY 2025 results with net sales of $1.76B and cost of sales $1.27B, yielding gross margin $498.3M. Operating income reached $299.0M after $184.3M SG&A, $40.7M R&D/engineering, $33.8M equity/royalty income, and -$8.1M other operating expense. Interest expense $33.4M and other income $600K led to pre-tax income $266.2M. Income tax expense $58.8M resulted in net income $207.4M. Basic EPS $3 on 82.2M shares, diluted $2 on 82.8M shares. Total assets $1.35B, equity $378.5M with retained earnings $454.6M offset by -$68.1M comprehensive loss and -$80.7M treasury stock. No prior year figures disclosed for direct comparison.
Net sales totaled $1.76B for FY 2025. No segment breakdowns, geographic mix, or growth drivers explicitly detailed in the filing. Gross margin derived from $1.76B sales minus $1.27B cost of sales. Equity, royalty and interest income from investees contributed $33.8M to operating results. No further revenue composition provided.
Gross margin $498.3M on $1.76B sales equates to 28.4%. Operating margin $299.0M / $1.76B = 17.0%. SG&A $184.3M (10.5% of sales), R&D $40.7M (2.3% of sales). Positive equity income $33.8M offset other operating expense -$8.1M. Net income margin 11.8%. Impairment charges $8.4M impacted profitability. No prior period margins for trend analysis.
Operating cash flow $202.7M driven by $207.4M net income, $30.0M depreciation, $18.7M deferred taxes, $12.4M share-based comp, offset by working capital changes including $55.2M receivables improvement. Capex $53.9M led to free cash flow $148.8M. Financing outflows $101.7M from $60.7M stock repurchases, $17.3M dividends, $22.5M debt paydown. Cash increased $52.1M to $236.4M. Current assets $892.4M vs. $368.2M current liabilities. Total debt $570.0M, equity $378.5M.
No management guidance, strategic priorities, or risk factors explicitly disclosed in the provided filing content.